• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Mesalazine
    8 Drugs classified under this active ingredient


    All the Active Ingredient Drugs

    Filter by letter: ALL A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
    Asacol
    Tradis Gat
    RX
    full basket chart
    Asacol

    5-Aminosalicylic Acid Derivative. Mesalazine 400 mg, 800 mg.
    TABS: 100 x 400 mg. 3-6 tabs. dly. in div.
    doses bef. meals.
    TABS: 60 x 800 mg. Ulc. colit: Maint.
    remission: 1.2-2.4 g dly in div. doses
    bef. meals. Chron’s dis: 2.4 g dly in div.
    doses bef. meals. Child: No specif.
    dose.
    Maint. remission in ulcerat. colit., acute
    episodes Crohn’s dis.
    Ulcerat. proctit.
    C/I: Hypersens. to salicylates, liver and
    kidney funct. disords., gastric or duod.
    ulc., pregn., lact., diabetes.

    Mezavant 1200 mg
    Medison
    RX
    not in the basket chart
    Mezavant 1200 mg

    Aminosalicyclic Acid. Mesalazine 1200 mg.
    GAST.-RESIST. PROLONG. REL. TABS.:60.  Adult., include. the elder. (>65 yrs.)
    For induct.of remis.: 2.4 - 4.8g (2-4 tabs.) should be taken once dly. The highest dose of 4.8g/d is recomm.  for pts. not respond. to lower doses of mesalazine. When using the highest dose (4.8g/d), the effect of the tmt. should be evaluat.at 8 wks. For mainten. of remis.: 2.4g (two tablets) should be taken once dly.
    For the induct. of clinic.& endoscop. remis. in pts. with mild to moder., act. ulcerat. colitis. For maintenan. of remiss.
    C/I: History of hypersens.  to salicylates (includ. mesalazine). Sev. renal impair. (GFR <30ml/min/1.73m²) and/or severe hep. impair.

    Pentasa Prolonged Release Tablets
    Ferring Pharmaceuticals
    RX
    full basket chart
    Pentasa Prolonged Release Tablets

    5-Aminosalicylic Acid Derivative. Mesalazine 500 mg, 1 g.
    S.R. TABS: 100 x 500 mg, 60 x 1 g. Ulcerat.
    colit: Active dis: Up to 4 g dly in div.
    doses. Child: Individ. dose. Initial: 50
    mg/kg bdy wt. dly in div. doses. Maint:
    2 g 1 x dly. Child: Individ. dose: 50 mg/
    kg bdy wt. dly in div. doses. Crohn’s dis:
    Active dis: Individ. dose: Up to 4 g dly
    in div. doses. Child: Individ. dose:
    Initial: 50 mg/kg bdy wt. dly in div.
    doses. Maint: Individ. dose: Up to 4 g
    dly in div. doses as reqd. Child: Individ.
    dose: 50 mg/kg bdy wt. dly in div.
    doses.
    Crohn’s dis., ulcerat. colit.
    C/I:
    Severe liver/ren. impair., hypersens.
    to mesylates/salicylates.

    Pentasa Retention Enema
    Ferring Pharmaceuticals
    RX
    full basket chart
    Pentasa Retention Enema

    5-Aminosalicylic Acid Derivative. Mesalazine 1 g/ 100 ml.
    RETENTION ENEMA: 7 x 1 g/100 ml.
    1 dly at bedt. See pt. leaflet.
    Crohn’s dis., ulcerat. colit.
    C/I: Severe liver/ren. impair., hypersens.
    to mesylates/salicylates.

    Pentasa Sachet Prolonged Release Granules
    Ferring Pharmaceuticals
    RX
    partial basket chart
    Pentasa Sachet Prolonged Release Granules

    5-Aminosalicylic Acid Derivative. Mesalazine 1, 2, 4 g.
    SACHETS: 100 x 1 g, 2 g, 4 g. Ulcerat.
    colit: Active dis: Up to 4 g dly in div.
    doses. Child: Individ. dose. Initial: 50
    mg/kg bdy wt. dly in div. doses. Maint:
    2 g 1 x dly. Child: Individ. dose: 50 mg/
    kg bdy wt. dly in div. doses. Crohn’s dis:
    Active dis: Individ. dose: Up to 4 g dly
    in div. doses. Child: Individ. dose:
    Initial: 50 mg/kg bdy wt. dly in div.
    doses. Maint: Individ. dose: Up to 4 g
    dly in div. doses as reqd. Child: Individ.
    dose: 50 mg/kg bdy wt. dly in div.
    doses.
    Crohn’s dis., ulcerat. colit.
    C/I:
    Severe liver/ren. impair., hypersens.
    to mesylates/salicylates.

    Pentasa Suppositories
    Ferring Pharmaceuticals
    RX
    full basket chart
    Pentasa Suppositories

    5-Aminosalicylic Acid Derivative. Mesalazine 1 g.
    SUPPS: 28 x 1 g. 1 supp 1-2 x dly. See
    pt. leaflet.
    Ulcerat. proctit.
    C/I: Severe liver/ren. impair., hypersens.
    to mesylates/salicylates.

    CLOSE